The global First-in-Human (FIH) Supplies market size is predicted to grow from US$ 226 million in 2025 to US$ 381 million in 2031; it is expected to grow at a CAGR of 9.0% from 2025 to 2031.

First-in-Human (FIH) Supplies refer to the initial batch of a new drug or therapeutic product that is produced specifically for the first clinical trials conducted in human subjects. This phase typically follows extensive preclinical testing and is crucial for assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of the drug in humans.FIH Supplies are intended for use in Phase I clinical trials, where the primary goal is to evaluate the safety and dosage of the drug in a small group of healthy volunteers or patients.The manufacturing of FIH Supplies must comply with Good Manufacturing Practice (GMP) regulations to ensure the quality, safety, and consistency of the drug product.The quantities produced for FIH Supplies are often smaller than those for later phase trials, as they are primarily focused on initial safety assessments rather than efficacy.

United States market for First-in-Human (FIH) Supplies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for First-in-Human (FIH) Supplies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for First-in-Human (FIH) Supplies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key First-in-Human (FIH) Supplies players cover PharmSky, ICON plc, Upperton Limited, Altus, Almac Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the ?First-in-Human (FIH) Supplies Industry Forecast? looks at past sales and reviews total world First-in-Human (FIH) Supplies sales in 2024, providing a comprehensive analysis by region and market sector of projected First-in-Human (FIH) Supplies sales for 2025 through 2031. With First-in-Human (FIH) Supplies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world First-in-Human (FIH) Supplies industry.

This Insight Report provides a comprehensive analysis of the global First-in-Human (FIH) Supplies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on First-in-Human (FIH) Supplies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global First-in-Human (FIH) Supplies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for First-in-Human (FIH) Supplies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global First-in-Human (FIH) Supplies.

This report presents a comprehensive overview, market shares, and growth opportunities of First-in-Human (FIH) Supplies market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Capsule
    Tabella
    Other

Segmentation by Application:

    Pharmaceutical Companies
    Contract Research Organizations (CROs)
    Academic Institutions and Research Centers
    Medical Device Companies

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    PharmSky
    ICON plc
    Upperton Limited
    Altus
    Almac Group
    Crystal Pharmatech Co., Ltd
    Quotient Sciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global First-in-Human (FIH) Supplies market?
What factors are driving First-in-Human (FIH) Supplies market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do First-in-Human (FIH) Supplies market opportunities vary by end market size?
How does First-in-Human (FIH) Supplies break out by Type, by Application?